Ultrasound and clinical factors predicting central lymph node metastases in patients with unilateral multifocal papillary thyroid carcinoma

Zhenwei Liang,Jixin Zhang,Lei Chen,Jinghua Liu,Fumin Wang,Yuhong Shao,Xiuming Sun,Luzeng Chen
DOI: https://doi.org/10.1111/ajco.14070
2024-04-26
Asia-Pacific Journal of Clinical Oncology
Abstract:This retrospective study involving a large dataset of unilateral multifocal papillary thyroid carcinoma (UM‐PTC) sought to identify factors that predict central lymph node metastases in patients. Preoperative assessment of clinical characteristics and sonographic features may guide the selection of PTC patients who are likely to benefit from prophylactic central neck surgery. Objective This retrospective study involving a large dataset of unilateral multifocal papillary thyroid carcinoma (UM‐PTC) sought to identify factors that predict central lymph node metastases (CLNM) in patients. Methods We identified a cohort of 158 patients who underwent cervical ultrasonography followed by UM‐PTC diagnosis based on postoperative pathology. The relationship between CLNM and UM‐PTC clinical ultrasound features was evaluated using univariate and multivariate analyses. Receiver operating characteristic (ROC) curve analysis was used to determine the ability of total tumor diameter (TTD) to predict CLNM. Results Among the 158 UM‐PTC patients, the incidence of CLNM was 29.7% (47/158). Univariate and multivariate analyses revealed that a number of similarity of sonographic features (NSSF) ≥4 (odds ratio [OR] = 11.335, 95% confidence interval [CI]: 3.95–32.50, p = 0.000), microcalcifications (OR = 3.54, 95% CI: 1.30–9.70, p = 0.014), a TTD of ≥2 cm (OR = 4.48, 95% CI: 1.62–12.34, p = 0.004), number of nodules ≥3 (OR = 13.17, 95% CI: 3.24–53.52, p = 0.000), and Lateral cervical lymph node metastasis (LLNM) (OR = 5.57, 95% CI: 1.59–19.48, p = 0.007) were independently associated with CLNM in UM‐PTC. ROC curve analysis revealed that the TTD cut‐off of 1.795 cm had a sensitivity of 0.723 and a specificity of 0.676 for predicting CLNM. Conclusions Patients with UM‐PTC are at high risk of CLNM. NSSF ≥4, microcalcifications, TTD of ≥2 cm, LLNM, and a number of nodules ≥3 were independently associated with CLNM. Our data show that ultrasound may guide surgical decisions in the treatment of UM‐PTC.
oncology
What problem does this paper attempt to address?